Overview
The Nuclear Medicine Department combines molecular imaging and radionuclide therapy for both diagnosis and targeted treatment. The department integrates advanced technology for accurate cancer staging, neurological evaluation, and functional organ imaging.
Advanced Technology:
Siemens Dual Head Symbia Evo SPECT System provides high-resolution imaging for organ-specific diagnostics.
AI-enabled uMI 780 Digital PET-CT with a 160-slice CT allows precise disease detection with low radiation exposure.
The high-dose radioisotope therapy isolation ward ensures radiation safety and patient comfort.
Sentinel imaging probe technology enables intraoperative tumor and lymph node mapping.
Commonly Performed Procedures:
SPECT Imaging includes thyroid, renal, cardiac perfusion, bone, and breast imaging along with sentinel node mapping.
PET-CT scans are used for cancer detection, dementia, Parkinson’s disease evaluation, and cardiac viability studies.
Targeted radionuclide therapies include PSMA therapy for prostate cancer, DOTA therapy for neuroendocrine tumors, and radioiodine therapy for thyroid diseases.
